NCT02491541View on ClinicalTrials.gov

A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

1,200

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2013

Conditions

Rabies

Interventions

BIOLOGICAL

Changchun Werersai

"A rabies vaccine (Vero Cell) for human use produced by Changchun Werersai Biotech Pharmaceutical Co., Ltd.~1.0 ml experimental vaccine on day 0,3,7,14,28"

BIOLOGICAL

Jilin Maifeng

"A rabies vaccine (Vero Cell) for human use produced by Jilin Maifeng Biotech Pharmaceutical Co., Ltd.~1.0 ml comparator vaccine on day 0,3,7,14,28"

Trial Locations (1)

221400

Xinyi Center for Disease Control and Prevention, Xuzhou

All Listed Sponsors

lead

Jiangsu Province Centers for Disease Control and Prevention

NETWORK

NCT02491541 - A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter